Chang Jin Wang
Fondateur chez FRONTIER BIOTECHNOLOGIES INC.
Fortune : 19 M $ au 31/05/2024
Postes actifs de Chang Jin Wang
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| FRONTIER BIOTECHNOLOGIES INC. | Directeur/Membre du Conseil | 15/01/2013 | - |
| Directeur Général | 15/01/2013 | - | |
| Fondateur | 15/01/2013 | - |
Historique de carrière de Chang Jin Wang
Anciens postes connus de Chang Jin Wang
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Abmaxis, Inc.
 Abmaxis, Inc. Pharmaceuticals: MajorHealth Technology Abmaxis Inc. develops pharmaceutical drugs. The company discovers and optimizes monoclonal antibody (mAb) products for human therapeutics and diagnostics. It has developed antibody engineering technology platform, Abmaxis in-silico Immunization (AISIM TM), which they are used for building an internal product pipeline and collaboration with global biotech and pharmaceutical partners. The company was founded in 2000 and is located in Santa Clara, CA. | Corporate Officer/Principal | 01/03/2005 | 01/07/2006 |
TaiGen Biotechnology Co., Ltd.
 TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Corporate Officer/Principal | 01/04/2002 | 01/05/2004 |
| VIVUS, INC. | Corporate Officer/Principal | 01/11/2006 | - |
Formation de Chang Jin Wang
| University of Kentucky | Doctorate Degree |
| West China University of Medical Sciences | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
| Chine | 3 |
| Taïwan | 2 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| FRONTIER BIOTECHNOLOGIES INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
VIVUS, Inc.
 VIVUS, Inc. Pharmaceuticals: MajorHealth Technology VIVUS, Inc. engaged in the development and commercialization of novel therapeutic products. The firm’s products were indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and it was headquartered in Campbell, CA. | Health Technology |
Abmaxis, Inc.
Abmaxis, Inc. Pharmaceuticals: MajorHealth Technology Abmaxis Inc. develops pharmaceutical drugs. The company discovers and optimizes monoclonal antibody (mAb) products for human therapeutics and diagnostics. It has developed antibody engineering technology platform, Abmaxis in-silico Immunization (AISIM TM), which they are used for building an internal product pipeline and collaboration with global biotech and pharmaceutical partners. The company was founded in 2000 and is located in Santa Clara, CA. | Health Technology |
TaiGen Biotechnology Co., Ltd.
TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Health Technology |
- Bourse
- Insiders
- Chang Jin Wang
- Expérience
